News
Eton Pharmaceuticals is able to buy orphan drugs from large pharma companies, where they are too small to matter. Read why ...
The popularity of nicotine pouches has surged, with the American Lung Association reporting a 641% increase in use from 2019 to 2022, predominantly ...
The agency is planning a new review process that could result in ingredient bans or additional labeling requirements, ...
Quince Therapeutics advances Ataxia-Telangiectasia treatment with innovative AIDE platform, insider support, and NEAT Phase 3 ...
Health and Human Services Secretary Robert F. Kennedy Jr. said Wednesday the Food and Drug Administration should change the ...
The White House on May 5, 2025 issued an executive order requiring the US Food and Drug Administration to find ways to facilitate the opening of ...
At the start of this month, the firm received an expanded FDA label approval for Uplizna. The FDA has approved it as the first treatment for Immunoglobulin G4-related disease (IgG4-RD) for adults.
If phase 3 trials of MM120 (lysergide d-tartrate) for anxiety and depression are successful, could the LSD-based drug become ...
"The biggest thing that will shock most readers of this report is just how different the findings in this study are from what the FDA claims on the abortion drug label," Katie Glenn Daniel ...
President Donald Trump has ordered the FDA to cut down the time it takes to approve pharmaceutical manufacturing plants in the U.S. The new executive order also sets the groundwork for the FDA to ...
This study identified various ADRs associated with amlodipine, and since the FDA label has already noted most of them without in-depth discussion, such as myocardial depression, metabolic acidosis, ...
They submitted an amicus brief in support of the FDA in ACLA, et al. v FDA. Yet amid all the challenges of today, an under-the-radar court ruling may be among the most significant harbingers of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results